Sunday March 18, 2018
Home India Hindi-Hebrew ...

Hindi-Hebrew great combo for global start-up ecosystem, says Israeli Ambassador Daniel Carmon

Silicon Valley is considered the global capital for start-ups, and Hindi and Hebrew are heard more than English

Israel Ambassador to India, Daniel Carmon ( in the centre). Image source:

Gurgaon, Aug 13: Guess what are the most spoken languages in Silicon Valley? It is not English but Hindi and Hebrew. Therefore, any India-Israel collaboration can create a vibrant ecosystem that will help start-ups to mushroom and thrive the world over, Israel’s Ambassador to India Daniel Carmon said.

“Start-ups constitute one of the pillars in further strengthening India-Israel relations,” Carmon told IANS, while announcing the Indian winners who will participate at this year’s Start Tel Aviv- a global event that brings to one platform entrepreneurs from across the world.

Benjamin Netanyahu. Image source: Wikimedia Commons
Benjamin Netanyahu. Image source: Wikimedia Commons

Quoting Israel’s Prime Minister Benjamin Netanyahu, the ambassador said that in the Silicon Valley, considered the global capital for start-ups, Hindi and Hebrew are heard more than English.

On the USA’s East Coast, Indians and Israelis already dominate the diamond business.

“If the people from India and Israel dominate the start-up space in Silicon Valley, why can’t they meet more often in New Delhi or Tel Aviv? I think start-ups provide great opportunities for people of both the countries who share common goals and aspirations,” he added.

Follow NewsGram on Twitter

“Proud of their history and tradition, India and Israel are two countries with a large population of young people, eager and curious to grasp the future,” the ambassador said.

“Let’s do it together.”

Ambassador Carmon said the initiative in start-ups was just one of the pillars identified to push India-Israel relations. He identified the others as agriculture, water ecosystem, defence, homeland security, education and academia.

XLPAT Lab co-founder Komal Talwar and Advenio’s Mausumi Acharyya were picked as the winners of the “Start Tel Aviv – India Finals” competition. They will join founders from 22 other countries for an intense, five-day start-up experience in Tel Aviv from September 25 to 29 this year.

“It is for the first time that the competition is focusing on women. We want to bring the women entrepreneurs to the front of the stage to take their rightful place in the start-up world,” said Ditza Froim, Minister-Counsellor for Public Diplomacy at the Israeli Embassy.

Talwar’s XLPAT boasts of patent and technology coverage of over 120 countries which allows users thorough and exhaustive patent searches within minutes and also generate claim charts.

Follow NewsGram on Facebook

Focussing in the field of computer aided diagnosis, Acharyya’s Advenio is developing a software to analyse hundreds of medical images to help doctors arrive at quick decisions about a medical problems.

Start Tel Aviv is organised to help promising early-stage start-ups to meet and establish relationships with potential customers, partners and high-profile industry leaders. (IANS)


Click here for reuse options!
Copyright 2016 NewsGram

Next Story

Pentavalent vaccine: Doctors raise red flag

In spite of the data presented in this paper from a large cohort, the authors point out that the evidence is merely circumstantial and not conclusive

the new Hepatitis B vaccine for adults is called Heplisav-B.
India's PV to be reexamined because of its harmful effects. .
  • Pentavalent vaccine was introduced in India six years ago
  • It is since then have been a cause of many deaths
  • Doctors want it to be reexamined before continuing its use

Pentavalent vaccine (PV), that was introduced by India a little over six years ago, doubled the deaths of children soon after vaccination compared to the DPT (Diphtheria-Pertussis-Tetanus) vaccine, according to a new study that calls for a “rigorous review of the deaths following vaccination with PV”.

Health officials have launched a campaign targeting nearly 24 million people with a one-fifth dose of the vaccine. Wikimedia Commons
PV has been cause of many deaths in past years. Wikimedia Commons

Government records show that there were 10,612 deaths following vaccination (both PV and DPT) in the last 10 years. There was a huge increase in these numbers in 2017, which the Health Ministry has promised to study. “The present analysis could be a starting point in the quest to reduce the numbers of such deaths,” authors of the new study say.

The study by Dr Jacob Puliyel, Head of Pediatrics at St Stephens Hospital, and Dr V. Sreenivas, Professor of Biostatistics at the All-India Institute of Medical Sciences (AIIMS), both in New Delhi, is published in the peer-reviewed Medical Journal of Dr D.Y. Patil University.

PV is a combination of the DPT vaccine and two more vaccines against Haemophilus influenza type B (Hib) and hepatitis B. Starting December 2011, PV was introduced into India’s immunisation programme to replace DPT vaccine in a staged manner with a view to adding protection against Hib and Hepatitis B without increasing the number of injections given to infants.

Doctors have raised concerns over these vaccines. Wikimedia Commons
Doctors have raised concerns over these vaccines. Wikimedia Commons

But sporadic reports of unexplained deaths following immunisation with PV had been a matter of concern. Puliyel, Sreenivas and their colleagues undertook the study to find out if these deaths were merely coincidental or vaccine-induced.

The authors obtained data of all deaths reported from April 2012 to May 2016 under the Right to Information Act. Data on deaths within 72 hours of administering DPT and PV from different states were used.

For their study, the authors assumed that all deaths within 72 hours of receiving DPT are natural deaths. Using this figure as the baseline, they presumed that any increase in the number of deaths above this baseline among children receiving PV must be caused by this vaccine.

Also Read: With Medicine Running Out, Venezuelans With Transplant Live in Fear

According to their analysis of the data provided by the government, there were 237 deaths within 72 hours of administering the Pentavalent vaccine — twice the death rate among infants who received DPT vaccine.

Extrapolating the data, the authors have estimated that vaccination of 26 million children each year in India would result in 122 additional deaths within 72 hours, due to the switch from DPT to PV.

“There is likely to be 7,020 to 8,190 deaths from PV each year if data from states with the better reporting, namely Manipur and Chandigarh, are projected nationwide,” their report says.

It is important to make sure that these vaccines are reexamined peroperly. VOA

The authors note that while the study looks at the short-term increase in deaths (within three days of vaccination) it does not calculate the potential benefits of PV on infant mortality, for example by protection against lethal diseases like Haemophilus influenza.

In spite of the data presented in this paper from a large cohort, the authors point out that the evidence is merely circumstantial and not conclusive. “These findings of differential death rates between DPT and PV do call for further rigorous prospective population-based investigations,” the study concludes. IANS